atai Life Sciences (ATAI) Misses Q3 EPS by 1c; Reports Cash and Cash Equivalents of $430.3M

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. MRVL

Go back to atai Life Sciences (ATAI) Misses Q3 EPS by 1c; Reports Cash and Cash Equivalents of $430.3M

UPDATE: Roth Capital Starts atai Life Sciences N.V (ATAI) at Buy

November 11, 2021 4:17 AM EST

(Updated - November 11, 2021 4:24 AM EST)

Roth Capital analyst Elemer Piros initiates coverage on atai Life Sciences N.V (NASDAQ: ATAI) with a Buy rating and a price target of $32.00.

The analyst comments "We arrive at our 12-month price target of... More